1.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: EORTC-16864A
|
|
2.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 75 and under
Sponsor:
Protocol IDs: EORTC-16864B
|
|
3.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 to 74
Sponsor:
Protocol IDs: EORTC-16864C
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 75 and under
Sponsor:
Protocol IDs: EORTC-16864D
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 75 and under
Sponsor:
Protocol IDs: EORTC-16864G
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 to 75
Sponsor:
Protocol IDs: EORTC-16864E
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 17 to 74
Sponsor:
Protocol IDs: EORTC-16864F
|
|
8.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: OSU-85HO193, OSU-IOU-8520, NCI-T85-0168W, T85-0168
|
|
9.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: WRAMC-8504, NCI-85-C-201, NCI-T86-0017N, T86-0017
|
|
10.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: UMCC-8520, NCI-T86-0004W, T86-0004
|
|
11.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: UTHSC-8565011052, NCI-T85-0244W, T85-0244
|
|
12.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MAYO-850106, NCI-T86-0060W, T86-0060
|
|
13.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: under 21
Sponsor: NCI
Protocol IDs: SJCRH-FAA, NCI-T86-0220D, T86-0220
|
|
14.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: BRMP-8711B, NCI-88-C-18B, NCI-T88-0030N, T88-0030
|
|
15.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: UKM-CRC-PHASE-I, NCI-T85-0255A, T85-0255
|
Mobile | Español
